서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 33 of 33

Issue DateTitle / Author(s) / CitationFileAltmetrics
2010-08
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
DOI
2010-11
Trastuzumab for gastric cancer treatment Reply

Bang, Yung-Jue; Van Cutsem, Eric; Lehle, Michaela; Hill, Julie

The Lancet, Vol.376 No.9754, pp.1735-1736

DOI
2011-02
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
DOI
2012-12
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
DOI
2013-05
Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
DOI
2013-11
Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
DOI
2013-11
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
DOI
2014-07
Quality of Life in the Trastuzumab for Gastric Cancer Trial
DOI
2015-07
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
DOI
2016-03
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
DOI
2018-01
Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma
DOI
2019-03
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
DOI
2019-07
Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer
DOI
2019-12
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

Hammel, P.; Kindler, H. L.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D-Y; Reinacher-Schick, A.; Tortora, G.; Alguel, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. Y.; Joo, S.; Yoo, H. K.; Patel, N.; Golan, T.; Chantrill, Lorraine; Goldstein, David; Joubert, Warren; Pavlakis, Nick; Tognela, Annette; Van Cutsem, Eric; Van Fraeyenhove, Frank; Van Laethem, Jean-Luc; Peeters, Marc; Dhani, Neesha; Kavan, Petr; Lemay, Frederic; Adenis, Antoine; Artru, Pascal; Hamed, Nabil; Belletier, Christine; Ben Abdelghani, Meher; Blanc, Jean-Frederic; Borg, Christophe; Coriat, Romain; Deplanque, Gael; Faroux, Roger; Follana, Philippe; Guimbaud, Rosine; el Hajbi, Farid; Hammel, Pascal; Hautefeuille, Vincent; Malka, David; Metges, Jean-Philippe; Tougeron, David; Walter, Thomas; Alguel, Hana; Ettrich, Thomas; Hacker, Ulrich Thorsten; Hennes, Elke; Jacobasch, Lutz; Kanzler, Stephan; Pession, Ursula; Reinacher-Schick, Anke; Scholz, Christian; Sinn, Marianne; Stein, Alexander; Strassburg, Christian; Vogel, Arndt; Ben-Shahar, Menachem; Brenner, Ronen; Epelbaum, Ron; Geva, Ravit; Gluzman, Alexander; Golan, Talia; Idelevich, Efraim; Kolin, Maya; Semenisty, Valeriya; Shai, Ayelet; Stemmer, Salomon; Yarom, Nirit; Celio, Luigi; Conte, Pierfranco; Garufi, Carlo; Gianni, Luca; Leonardi, Francesco; Maiello, Evaristo; Di Marco, Mariacristina; Milella, Michele; Pinto, Carmine; Santini, Daniele; Scartozzi, Mario; Tortora, Giampaolo; Vaccaro, Vanja; Vasile, Enrico; Kim, Ji-Won; Kim, Jin-Won; Oh, Youn; Park, Joon Oh; Wilmink, Hanneke; Alvarez Gallego, Rafael; Duran Ogalla, Gema; Garcia Velasco, Adelaida; Garralda Cabanas, Elena; Gomez Martin, Carlos; Guillen Ponce, Carmen; Laquente Saez, Berta; Lopez, Rafael; Macarulla, Teresa; Munoz Martin, Andres; Pazo, Roberto; Pericay Pijaume, Carles; Rodriguez, Javier; Yaya-Tur, Ricardo; Arora, Arvind; Anthoney, David Alan; Evans, T. R. Jeffrey; Harrison, Mark; Hochhauser, Daniel; Palmer, Daniel; Sarker, Debashis; Starling, Naureen; Valle, Juan; Wall, Lucy; Agajanian, Richy; Bearden, James; Bekaii-Saab, Tanios; Carter, Corey; Cohen, Deirdre; DiStefano, Alfred; Dragovich, Tomislav; Ejadi, Samuel; Ford, James; Grabelsky, Stephen; Hall, Michael; Hochster, Howard; Hosein, Peter; Javle, Milind; Kindler, Hedy; Lacy, Jill; Laheru, Daniel; Leong, Stephen; Lowery, Maeve; Marsh, Robert; Noonan, Anne; Oberstein, Paul; Ocean, Allyson; O'Reilly, Eileen; Ryan, David; Seery, Tara; Subramaniam, Somasundaram; Van Echo, David; Wang-Gillam, Andrea; Weekes, Colin; Welch, Stephen

Annals of Oncology, Vol.30 No.12, pp.1959-1968

DOI
2020-05
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
DOI
2020-09
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
DOI
2020-10
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
DOI
2021-03
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
DOI
2021-04
Efficacy of pembrolizumab monotherapy for advanced gastric/gastroesophageal junction cancer with programmed death ligand 1 combined positive score ≥10
DOI
2021-06
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
DOI
2021-10
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
DOI
2021-11
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061
DOI
2022-01
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
DOI
2022-08
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study
DOI
2022-09
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel +/- Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
DOI
2022-12
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
DOI
2023-03
Zolbetuximab + CAPOX in 1L claudin-18.2+(CLDN18.2+)/HER2-locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
DOI
2023-04
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial

Tempero, Margaret A.; Pelzer, Uwe; O'Reilly, Eileen M.; Winter, Jordan; Oh, Do-Youn; Li, Chung-Pin; Tortora, Giampaolo; Chang, Heung-Moon; Lopez, Charles D.; Bekaii-Saab, Tanios; Ko, Andrew H.; Santoro, Armando; Park, Joon Oh; Noel, Marcus S.; Frassineti, Giovanni Luca; Shan, Yan-Shen; Dean, Andrew; Riess, Hanno; Van Cutsem, Eric; Berlin, Jordan; Philip, Philip; Moore, Malcolm; Goldstein, David; Tabernero, Josep; Li, Mingyu; Ferrara, Stefano; Le Bruchec, Yvan; Zhang, George; Lu, Brian; Biankin, Andrew V.; Reni, Michele; Epstein, Richard; Vasey, Paul; Shapiro, Jeremy; Burge, Matthew; Chua, Yu Jo; Harris, Marion; Pavlakis, Nick; Tebbutt, Niall; Prager, Gerald; Dittrich, Christian; Längle, Friedrich; Philipp-Abbrederis, Kathrin; Greil, Richard; Stöger, Herbert; Girschikofsky, Michael; Kuehr, Thomas; Van Laethem, Jean-Luc; Laurent, Stéphanie; Dhani, Neesha; Ko, Yoo Joung; Dowden, Scot; Kavan, Petr; Tehfe, Mustapha Édouard; Kubala, Eugen; Kohoutek, Milan; Pfeiffer, Per; Yilmaz, Mette; Parner, Vibeke; Salminen, Tapio; Soveri, Leena-Maija; Korkeila, Eija; Osterlund, Pia; Taieb, Julien; Tougeron, David; Artru, Pascal; Caroli-Bosc, François Xavier; Guimbaud, Rosine; Turpin, Antony; Walter, Thomas; Bachet, Jean Baptiste; Kunzmann, Volker; Kreth, Florian; Block, Andreas; Venerito, Marino; Oettle, Helmut; Karthaus, Meinolf; Trojan, Jörg; Folprecht, Gunnar; Lerch, Markus; Kullmann, Frank; Reiser, Marcel; Heinemann, Volker; Wörns, Marcus-Alexander; Schulz, Holger; Garlipp, Benjamin; Yau, Thomas; Chan, Lam Stephen; Juhasz, Balazs; Landherr, László; Pinter, Tamas; Bodoky, György; Kahán, Zsuzsanna; McDermott, Raymond; Power, Derek; Gianni, Luca; Siena, Salvatore; Milella, Michele; Falcone, Alfredo; Berardi, Rossana; Bagalà, Cinzia; Di Costanzo, Francesco; Roila, Fausto; Ardizzoni, Andrea; Maiello, Evaristo; Fanello, Silvia; Wilmink, Johanna; Willem De Groot, Jan; Creemers, Geert; Barroso, Eduardo; Rodrigues, Tânia; Sarmento, Cristina; Chee, Cheng Ean; Tai, David; Mercade, Teresa Macarulla; Medina, Manuel Hidalgo; Mena, Alfredo Carrato; Santasusana, Joan Maurel; Flor Oncala, Maria Jose; Martin, Carlos Gomez; Lopez, Rafael; Muñoz, Andres; Garcia, Ruth Vera; Ales, Inmaculada; Sáez, Berta Laquente; Rivera, Fernando; Sastre, Javier; Wu, Cheng-Chung; Tien, Yu-Wen; Chan, De-Chuan; Hwang, Tsann-Long; Evans, Jeffry; Wadsley, Jonathan; Corrie, Pippa; Biankin, Andrew; Ko, Andrew; Cardin, Dana; Chiorean, Elena; Bendell, Johanna; Noonan, Anne; Kindler, Hedy; Fernando, Nishan; Beg, Muhammad; George, Thomas; Noel, Marcus; Loconte, Noelle; Arena, Francis; Posey, James; Malhotra, Rajat; Lopez, Charles; Sohal, Davendra; McWilliams, Robert; Brenner, Warren; Womack, Mark; Seth, Rahul; Lyer, Renuka; Bahary, Nathan; Marsh, Robert; Ramirez, Robert; Chua, Cynthia; Reeves, James; Manji, Gulam; El-Khoueiry, Anthony; Weaver, Robert; Sahai, Vaibhav; Messersmith, Wells; Dreicer, Robert; Zakari, Ahmed; Bullock, Andrea; Musher, Benjamin; Borad, Mitesh; Kim, Edward; Bajor, David; Huyck, Tim; Hatoum, Hassan; Xiong, Henry; Pasche, Boris; Lacy, Jill; Olowokure, Olugbenga; Cohn, Allen; Richards, Donald; Martin, Robert; Paulson, Andrew; Fanta, Paul; Krishnamurthi, Smitha; Oberstein, Paul; Fuloria, Jyotsna; APACT Investigators

Journal of Clinical Oncology, Vol.41 No.11, pp.2007-2019

DOI
2023-04
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial
DOI
2023-05
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
DOI
2023-08
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
DOI
2024
Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary
DOI
2024-02
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
DOI
1